• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Addus HomeCare Announces Third Quarter 2024 Financial Results

    11/4/24 4:05:00 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care
    Get the next $ADUS alert in real time by email

    Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the third quarter and nine months ended September 30, 2024.

    Third Quarter 2024 Highlights:

    • Net Service Revenues Increase 7.0% to $289.8 Million
    • Net Income of $20.2 Million, or $1.10 per Diluted Share
    • Adjusted Net Income per Diluted Share Increases 13.0% to $1.30
    • Adjusted EBITDA Increases 11.1% to $34.3 Million
    • Cash Flow from Operations of $48.5 Million

    Overview

    Net service revenues were $289.8 million for the third quarter of 2024, a 7.0% increase compared with $270.7 million for the third quarter of 2023. Net income was $20.2 million for the third quarter of 2024, compared with $15.4 million for the third quarter of 2023, while net income per diluted share was $1.10 compared with $0.95 for the same period a year ago. Adjusted EBITDA increased 11.1% to $34.3 million for the third quarter of 2024 from $30.9 million for the third quarter of 2023. Adjusted net income was $23.8 million for the third quarter of 2024 compared with $18.8 million for the prior-year period, while adjusted net income per diluted share was $1.30 compared with $1.15 for the third quarter of 2023. Adjusted net income per diluted share for the third quarter of 2024 excludes acquisition expenses of $0.08 and stock-based compensation expense of $0.12. The weighted average number of shares outstanding increased to approximately 18.3 million from approximately 16.5 million in the second quarter primarily as a result of the completed public offering of 1,725,000 shares on June 28, 2024 (See the end of press release for a reconciliation of all non-GAAP and GAAP financial measures.)

    For the first nine months of 2024, net service revenues increased 9.6% to $857.5 million from $782.3 million for the prior-year period. Net income was $54.1 million for the first nine months of 2024 compared with $42.9 million for the same period in 2023, and net income per diluted share was $3.17 compared with $2.63 per diluted share. Adjusted EBITDA increased 19.4% to $102.0 million for the first nine months of 2024 from $85.4 million for the first nine months of 2023. Adjusted net income was $65.9 million for the first nine months of 2024 compared with $52.1 million for the first nine months of 2023, while adjusted net income per diluted share was $3.86 compared with $3.20 for the prior-year period.

    Commenting on the results, Dirk Allison, Chairman and Chief Executive Officer, said, "Addus delivered another strong financial and operating performance for the third quarter of 2024, highlighted by 7.0% top line growth and 11.1% growth in Adjusted EBITDA compared to the third quarter of 2023. These results reflect the consistent favorable growth trends we have delivered to date in 2024, driven by solid organic growth and the contribution from recent acquisitions. Demand for our services continues to fuel our growth, reflecting a greater awareness of the value of home-based care as the preferred and most cost-effective option for many individuals. With our expanding scale and market coverage, Addus is well positioned to meet this demand with our ability to offer home-based services across the care continuum.

    "Our personal care business continued to perform well, accounting for 74.3% of our overall revenues for the third quarter of 2024, with higher patient volumes supported by favorable hiring trends. Personal care has been the key growth driver for Addus this year with consistent year-over-year improvement. For the third quarter of 2024, we delivered 6.8% organic growth in revenue on a same-store basis over the corresponding period last year, reflecting robust demand and favorable reimbursement support across the markets where we operate.

    "On the clinical side, our results included the operations of Tennessee Quality Care, a provider of home health, hospice, and private duty nursing services, acquired by Addus on August 1, 2023. We continued to see steady improvement in our hospice business with revenues up 3.5% on a same-store basis and a modest increase in average daily census compared with the third quarter last year. Our home health business, which is our smallest segment, accounted for 5.9% of total revenue for the third quarter of 2024," said Allison.

    Cash and Liquidity

    As of September 30, 2024, the Company had cash of $222.9 million with capacity and availability under its revolving credit facility of $511.5 million and $503.5 million, respectively. Net cash provided by operating activities was $48.5 million for the third quarter of 2024, inclusive of a one-time working capital benefit of $9.7 million expected to revert in the fourth quarter. As previously disclosed, subsequent to the end of the quarter, Addus entered into an Amended and Restated Credit Agreement to increase the Company's revolving credit facility from $600 million to $650 million and extend the maturity date through July 2028.

    Looking Ahead

    Allison added, "We will continue to maintain a conservative balance sheet and pursue a capital allocation strategy that brings additional value to our shareholders. Acquisitions represent a significant use of capital for Addus, and we will continue to target operations that are aligned with our overall growth strategy to add clinical services where we have a strong personal care presence. We will also seek opportunities to add operations in select personal care markets where we can enter at scale. In line with this strategy, during the second quarter, we announced a definitive agreement to acquire the personal care operations of Gentiva. These operations deliver personal care services to over 16,000 patients per day in a seven-state service area, including Texas and Missouri, which are new states for Addus. We are excited about the opportunity to expand our market reach, especially in Texas where we will become the largest provider of personal care services. Having broader market coverage supports our ability to hire and retain caregivers and also provides Addus with an advantage in developing value-based contract arrangements. We expect to close the Gentiva acquisition in the fourth quarter of 2024, and our team has been diligently working on transition planning to integrate these operations.

    "As we continue to expand our operations, we are proud of the leadership role we are playing in meeting the critical need for home-based care. We commend the work of our dedicated caregivers across our operations who make this possible for more patients and their families. We are excited about the opportunities ahead to build on our momentum, and we look forward to another successful year for Addus in 2024," added Allison.

    Non-GAAP Financial Measures

    The information provided in this release includes adjusted net income, adjusted EBITDA, and adjusted net income per diluted share, which are non-GAAP financial measures. The Company defines adjusted net income as net income before gain or loss on sale of assets, impact of retroactive New York rate increases, acquisition expenses, stock-based compensation expenses, and restructure and other non-recurring costs. The Company defines adjusted EBITDA as earnings before interest expense, gain or loss on sale of assets, taxes, depreciation, amortization, impact of retroactive New York rate increases, acquisition expense, stock-based compensation expense, and restructure and other non-recurring costs. The Company defines adjusted net income per diluted share as net income per share, adjusted for the impact of retroactive New York rate increases, acquisition expenses, stock-based compensation expense, and restructure and other non-recurring costs. The Company defines adjusted net service revenues as revenue adjusted for the closure of certain sites. The Company has provided, in the financial statement tables included in this press release, a reconciliation of adjusted net income to net income, a reconciliation of adjusted EBITDA to net income, a reconciliation of adjusted diluted net income per share to net income per share, and a reconciliation of adjusted net service revenues to net service revenues, in each case, the most directly comparable GAAP measure. Management believes that adjusted net income, adjusted EBITDA, adjusted diluted net income per share, and adjusted net service revenues are useful to investors, management and others in evaluating the Company's operating performance, to provide investors with insight and consistency in the Company's financial reporting and to present a basis for comparison of the Company's business operations among periods, and to facilitate comparison with the results of the Company's peers.

    Conference Call

    Addus will host a conference call on Tuesday, November 5, 2024, at 9:00 a.m. Eastern time. To access the live call, dial (833) 629-0620 (international dial-in number is (412) 317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available through midnight on November 12, 2024, by dialing (877) 344-7529 (international dial-in number is (412) 317-0088) and entering pass code 4366280.

    A live broadcast of Addus HomeCare's conference call will be available under the Investor Relations section of the Company's website: www.addus.com. An online replay will also be available on the Company's website for one month, beginning approximately two hours following the conclusion of the live broadcast.

    Forward-Looking Statements

    Certain matters discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by words such as "preliminary," "continue," "expect," and similar expressions. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. Forward-looking statements involve a number of risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements, including discretionary determinations by government officials, the consummation and integration of acquisitions, transition to managed care providers, our ability to successfully execute our growth strategy, unexpected increases in SG&A and other expenses, expected benefits and unexpected costs of acquisitions and dispositions, management plans related to dispositions, the possibility that expected benefits may not materialize as expected, the failure of the business to perform as expected, changes in reimbursement, changes in government regulations, changes in Addus HomeCare's relationships with referral sources, increased competition for Addus HomeCare's services, changes in the interpretation of government regulations, the uncertainty regarding the outcome of discussions with managed care organizations, changes in tax rates, the impact of adverse weather, higher than anticipated costs, lower than anticipated cost savings, estimation inaccuracies in future revenues, margins, earnings and growth, whether any anticipated receipt of payments will materialize, any security breaches, cyber-attacks, loss of data or cybersecurity threats or incidents, and other risks set forth in the Risk Factors section in Addus HomeCare's Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 27, 2024, which is available at www.sec.gov. The financial information described herein and the periods to which they relate are preliminary estimates that are subject to change and finalization. There is no assurance that the final amounts and adjustments will not differ materially from the amounts described above, or that additional adjustments will not be identified, the impact of which may be material. Addus HomeCare undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In addition, these forward-looking statements necessarily depend upon assumptions, estimates and dates that may be incorrect or imprecise and involve known and unknown risks, uncertainties, and other factors. Accordingly, any forward-looking statements included in this press release do not purport to be predictions of future events or circumstances and may not be realized. (Unaudited tables and notes follow).

    About Addus HomeCare

    Addus HomeCare is a provider of home care services that primarily include personal care services that assist with activities of daily living, as well as hospice and home health services. Addus HomeCare's consumers are primarily persons who, without these services, are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Addus HomeCare's payor clients include federal, state, and local governmental agencies, managed care organizations, commercial insurers, and private individuals. Addus HomeCare currently provides home care services to over 48,500 consumers through 214 locations across 22 states. For more information, please visit www.addus.com.

     

    ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

    Condensed Consolidated Statements of Income

    (amounts and shares in thousands, except per share data)

    (Unaudited)

     
    Income Statement Information:

    For the Three Months

    Ended September 30,

     

    For the Nine Months

    Ended September 30,

    2024

     

    2023

     

    2024

     

    2023

     
    Net service revenues

    $

    289,787

     

    $

    270,721

     

    $

    857,455

     

    $

    782,300

     

    Cost of service revenues

     

    197,583

     

     

    183,991

     

     

    583,916

     

     

    534,837

     

     
    Gross profit

     

    92,204

     

     

    86,730

     

     

    273,539

     

     

    247,463

     

     

    31.8

    %

     

    32.0

    %

     

    31.9

    %

     

    31.6

    %

    General and administrative expenses

     

    62,805

     

     

    60,271

     

     

    187,444

     

     

    174,028

     

    Depreciation and amortization

     

    3,446

     

     

    3,620

     

     

    10,316

     

     

    10,449

     

    Total operating expenses

     

    66,251

     

     

    63,891

     

     

    197,760

     

     

    184,477

     

     
    Operating income

     

    25,953

     

     

    22,839

     

     

    75,779

     

     

    62,986

     

     
    Total interest expense, net

     

    (1,335

    )

     

    2,619

     

     

    2,640

     

     

    7,014

     

     
    Income before income taxes

     

    27,288

     

     

    20,220

     

     

    73,139

     

     

    55,972

     

    Income tax expense

     

    7,125

     

     

    4,809

     

     

    19,067

     

     

    13,034

     

     
    Net income

    $

    20,163

     

    $

    15,411

     

    $

    54,072

     

    $

    42,938

     

     
    Net income per diluted share:

    $

    1.10

     

    $

    0.95

     

    $

    3.17

     

    $

    2.63

     

     
    Weighted average number of common shares outstanding:

    Diluted

     

    18,255

     

     

    16,286

     

     

    17,065

     

     

    16,307

     

     
     
    Cash Flow Information:

    For the Three Months

    Ended September 30,

     

    For the Nine Months

    Ended September 30,

    2024

     

    2023

     

    2024

     

    2023

     
    Net cash provided by operating activities

    $

    48,525

     

    $

    21,785

     

    $

    106,016

     

    $

    82,198

     

    Net cash (used in) investing activities

     

    (1,922

    )

     

    (111,223

    )

     

    (124

    )

     

    (113,934

    )

    Net cash provided by financing activities

     

    2,944

     

     

    85,000

     

     

    52,169

     

     

    31,525

     

     
    Net change in cash

     

    49,547

     

     

    (4,438

    )

     

    158,061

     

     

    (211

    )

    Cash at the beginning of the period

     

    173,305

     

     

    84,188

     

     

    64,791

     

     

    79,961

     

    Cash at the end of the period

    $

    222,852

     

    $

    79,750

     

    $

    222,852

     

    $

    79,750

     

     

    ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

    Condensed Consolidated Balance Sheets

    (Amounts in thousands)

    (Unaudited)

     

     

     

     

     

    September 30,

     

    2024

     

    2023

     
    Assets
     
    Current assets
    Cash

    $

    222,852

    $

    79,750

    Accounts receivable, net

     

    96,600

     

    121,112

    Prepaid expenses and other current assets

     

    13,362

     

    10,387

     
    Total current assets

     

    332,814

     

    211,249

     
    Property and equipment, net

     

    23,716

     

    20,516

     
    Other assets
    Goodwill

     

    663,614

     

    662,981

    Intangible assets, net

     

    86,606

     

    93,799

    Operating lease assets

     

    44,535

     

    47,183

    Other long-term assets

     

    1,616

     

    -

    Total other assets

     

    796,371

     

    803,963

     
    Total assets

    $

    1,152,901

    $

    1,035,728

     
    Liabilities and stockholders' equity
     
    Current liabilities
    Accounts payable

    $

    27,726

    $

    21,375

    Accrued payroll

     

    57,982

     

    51,774

    Accrued expenses

     

    34,257

     

    34,952

    Operating lease liabilities - current portion

     

    11,155

     

    11,434

    Government stimulus advance

     

    13,655

     

    7,836

    Accrued workers compensation

     

    13,043

     

    12,268

    Total current liabilities

     

    157,818

     

    139,639

     
    Long-term debt, less current portion, net of debt issuance costs

     

    -

     

    163,917

    Long-term lease liability, less current portion

     

    38,608

     

    41,632

    Other long-term liabilities

     

    8,841

     

    6,206

    Total long-term liabilities

     

    47,449

     

    211,755

     
    Total liabilities

     

    205,267

     

    351,394

     
    Total stockholders' equity

     

    947,634

     

    684,334

     
    Total liabilities and stockholders' equity

    $

    1,152,901

    $

    1,035,728

     

    ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

    Net Service Revenue by Segment

    (Amounts in thousands)

    (Unaudited)

     

     

     

     

     

     

     

     

     

    For the Three Months

    Ended September 30,

     

    For the Nine Months

    Ended September 30,

     

    2024

     

    2023

     

    2024

     

    2023

    Net Service Revenues by Segment
     
    Personal Care

    $

    215,433

    $

    201,882

    $

    636,253

    $

    590,227

    Hospice

     

    57,309

     

    53,121

     

    169,202

     

    152,414

    Home Health

     

    17,045

     

    15,718

     

    52,000

     

    39,659

    Total Revenue

    $

    289,787

    $

    270,721

    $

    857,455

    $

    782,300

     

    ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

    Key Statistical and Financial Data (Unaudited)

     

     

     

     

     

     

     

     

     

     

     

    For the Three Months

    Ended September 30,

     

    For the Nine Months

    Ended September 30,

     

     

    2024

     

    2023

     

    2024

     

    2023

     
     
    Personal Care
     
    States served at period end

     

    -

     

     

    -

     

     

    21

     

     

    21

     

    Locations at period end

     

    -

     

     

    -

     

     

    153

     

     

    156

     

    Average billable census total

     

    37,701

     

     

    38,590

     

     

    37,803

     

     

    38,668

     

    Billable hours (in thousands)

     

    7,776

     

     

    7,690

     

     

    23,098

     

     

    22,964

     

    Average billable hours per census per month

     

    68.7

     

     

    66.3

     

     

    67.8

     

     

    65.8

     

    Billable hours per business day

     

    117,822

     

     

    118,314

     

     

    117,849

     

     

    117,765

     

    Revenues per billable hour

    $

    27.66

     

    $

    26.18

     

    $

    27.49

     

    $

    25.58

     

    Organic growth
    - Revenue

     

    6.8

    %

     

    13.9

    %

     

    8.4

    %

     

    12.5

     

     
    Hospice
     
    Locations served at period end

     

    -

     

     

    -

     

     

    38

     

     

    40

     

    Admissions

     

    3,105

     

     

    3,176

     

     

    9,771

     

     

    9,576

     

    Average daily census

     

    3,534

     

     

    3,453

     

     

    3,457

     

     

    3,426

     

    Average discharge length of stay

     

    96.3

     

     

    97.5

     

     

    92.8

     

     

    93.2

     

    Patient days

     

    325,160

     

     

    311,454

     

     

    947,241

     

     

    892,507

     

    Revenue per patient day

    $

    176.25

     

    $

    175.19

     

    $

    179.43

     

    $

    175.23

     

    Organic growth
    - Revenue

     

    3.5

    %

     

    3.1

    %

     

    5.2

    %

     

    1.5

     

    - Average daily census

     

    2.1

    %

     

    (0.9

    )%

     

    0.8

    %

     

    0.8

     

     
    Home Health
     
    Locations served at period end

     

    -

     

     

    -

     

     

    23

     

     

    24

     

    New Admissions

     

    4,437

     

     

    4,265

     

     

    14,257

     

     

    11,597

     

    Recertifications

     

    3,353

     

     

    2,672

     

     

    9,798

     

     

    5,816

     

    Total Volume

     

    7,790

     

     

    6,937

     

     

    24,055

     

     

    17,413

     

    Visits

     

    104,730

     

     

    94,637

     

     

    322,713

     

     

    240,758

     

    Organic growth
    - Revenue

     

    (1.7

    )%

     

    (8.8

    )%

     

    (5.4

    )%

     

    (2.5

    )

    - New admissions

     

    (5.7

    )%

     

    (18.9

    )%

     

    (0.3

    )%

     

    (13.5

    )

    - Volume

     

    (3.7

    )%

     

    (14.3

    )%

     

    (0.4

    )%

     

    (9.3

    )

     
    Percentage of Revenues by Payor:
     
    Personal Care
     
    State, local and other governmental programs

     

    54.2

    %

     

    50.4

    %

     

    53.0

    %

     

    50.4

     

    Managed care organizations

     

    43.3

     

     

    46.4

     

     

    44.3

     

     

    46.2

     

    Private duty

     

    1.7

     

     

    2.0

     

     

    1.8

     

     

    2.1

     

    Commercial

     

    0.7

     

     

    0.8

     

     

    0.7

     

     

    0.8

     

    Other

     

    0.1

    %

     

    0.4

    %

     

    0.2

    %

     

    0.5

     

     
    Hospice
     
    Medicare

     

    91.5

    %

     

    89.1

    %

     

    91.1

    %

     

    90.2

     

    Commercial

     

    5.0

     

     

    6.8

     

     

    5.2

     

     

    5.8

     

    Managed care organizations

     

    3.2

     

     

    3.4

     

     

    3.3

     

     

    3.3

     

    Other

     

    0.3

    %

     

    0.7

    %

     

    0.4

    %

     

    0.7

     

     
    Home Health
     
    Medicare

     

    70.6

    %

     

    72.1

    %

     

    69.6

    %

     

    73.9

     

    Managed care organizations

     

    24.7

     

     

    21.9

     

     

    25.6

     

     

    20.8

     

    Commercial

     

    4.5

     

     

    4.2

     

     

    4.2

     

     

    4.3

     

    Other

     

    0.2

    %

     

    1.8

    %

     

    0.6

    %

     

    1.0

     

     

    ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

    Reconciliation of Non-GAAP Financial Measures

    (Amounts in thousands, except per share data)

    (Unaudited) (1)

     

     

     

     

     

     

     

     

     

    For the Three Months

    Ended September 30,

     

    For the Nine Months

    Ended September 30,

     

    2024

     

    2023

     

    2024

     

    2023

    Reconciliation of Adjusted EBITDA to Net Income: (1)
     
    Net income

    $

    20,163

     

    $

    15,411

     

    $

    54,072

     

    $

    42,938

     

     
    Interest expense, net

     

    (1,335

    )

     

    2,619

     

     

    2,640

     

     

    7,014

     

    (Gain) Loss on sale of assets

     

    (8

    )

     

    (1

    )

     

    (13

    )

     

    (5

    )

    Income tax expense

     

    7,125

     

     

    4,809

     

     

    19,067

     

     

    13,034

     

    Depreciation and amortization

     

    3,446

     

     

    3,620

     

     

    10,316

     

     

    10,449

     

    Impact of retroactive New York rate increase

     

    -

     

     

    -

     

     

    -

     

     

    (868

    )

    Acquisition expenses

     

    2,072

     

     

    1,763

     

     

    7,647

     

     

    4,792

     

    Stock-based compensation expense

     

    2,833

     

     

    2,572

     

     

    8,307

     

     

    7,831

     

    Restructure and other non-recurring costs

     

    -

     

     

    72

     

     

    -

     

     

    242

     

    Adjusted EBITDA

    $

    34,296

     

    $

    30,865

     

    $

    102,036

     

    $

    85,427

     

     
     
    Reconciliation of Adjusted Net Income to Net Income: (2)
     
    Net income

    $

    20,163

     

    $

    15,411

     

    $

    54,072

     

    $

    42,938

     

     
    (Gain) Loss on sale of assets

     

    (8

    )

     

    (1

    )

     

    (13

    )

     

    (5

    )

    Impact of retroactive New York rate increase

     

    -

     

     

    -

     

     

    -

     

     

    (868

    )

    Acquisition expenses

     

    2,072

     

     

    1,763

     

     

    7,647

     

     

    4,792

     

    Stock-based compensation expense

     

    2,833

     

     

    2,572

     

     

    8,307

     

     

    7,831

     

    Restructure and other non-recurring costs

     

    -

     

     

    72

     

     

    -

     

     

    242

     

    Tax Effect

     

    (1,280

    )

     

    (1,048

    )

     

    (4,156

    )

     

    (2,793

    )

     
    Adjusted Net Income

    $

    23,780

     

    $

    18,769

     

    $

    65,857

     

    $

    52,137

     

     
     
    Reconciliation of Net Income per Diluted Share to Adjusted Net Income per Diluted Share: (3)
     
    Net income per diluted share

    $

    1.10

     

    $

    0.95

     

    $

    3.17

     

    $

    2.63

     

     
    Impact of retroactive New York rate increase per diluted share

     

    -

     

     

    -

     

     

    -

     

     

    (0.04

    )

    Acquisition expenses per diluted share

     

    0.08

     

     

    0.08

     

     

    0.33

     

     

    0.23

     

    Restructure and other non-recurring costs per diluted share

     

    -

     

     

    -

     

     

    -

     

     

    0.01

     

    Stock-based compensation expense per diluted share

     

    0.12

     

     

    0.12

     

     

    0.36

     

     

    0.37

     

     
    Adjusted net income per diluted share

    $

    1.30

     

    $

    1.15

     

    $

    3.86

     

    $

    3.20

     

     
    Reconciliation of Net Service Revenues to Adjusted Net Service Revenues: (4)
     
    Net service revenues

    $

    289,787

     

    $

    270,721

     

    $

    857,455

     

    $

    782,300

     

     
    Revenues associated with the closure of certain sites

     

    -

     

     

    (259

    )

     

    -

     

     

    (1,833

    )

     
    Adjusted net service revenues

    $

    289,787

     

    $

    270,462

     

    $

    857,455

     

    $

    780,467

     

     
     
    Footnotes
     
    (1) We define Adjusted EBITDA as earnings before net interest expense, income tax expense, depreciation and amortization, acquisition expenses, stock-based compensation expense, restructure expenses and other non-recurring costs, gain on the sale of assets, and retroactive rate increases from New York. Adjusted EBITDA is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.
    (2) We define Adjusted Net Income as net income before acquisition expenses, stock-based compensation expense, restructure and other non-recurring costs, gain on the sale of assets, and retroactive rate increases from New York. Adjusted Net Income is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.
    (3) We define Adjusted diluted earnings per share as earnings per share, adjusted for acquisition expenses, stock-based compensation expense and restructure and other non-recurring costs, gain on the sale of assets, and retroactive rate increases from New York. Adjusted diluted earnings per share is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.
    (4) We define Adjusted net service revenues as revenue adjusted for the closure of certain sites. Adjusted net service revenues is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20241104677875/en/

    Get the next $ADUS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADUS

    DatePrice TargetRatingAnalyst
    1/7/2026$135.00Buy
    Truist
    11/13/2025$120.00Market Perform
    BMO Capital Markets
    9/2/2025$145.00Buy
    UBS
    12/16/2024$150.00Mkt Outperform
    JMP Securities
    10/11/2024$150.00Overweight
    KeyBanc Capital Markets
    6/28/2024$136.00Outperform
    Macquarie
    4/23/2024$83.00Equal Weight → Underweight
    Barclays
    3/6/2024$88.00Equal Weight
    Barclays
    More analyst ratings

    $ADUS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Raines Monica decreased direct ownership by 18% to 12,045 units (SEC Form 5)

    5 - Addus HomeCare Corp (0001468328) (Issuer)

    2/12/26 5:00:25 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    Director Lopez Esteban sold $17,278 worth of shares (150 units at $115.18), decreasing direct ownership by 4% to 3,700 units (SEC Form 4)

    4 - Addus HomeCare Corp (0001468328) (Issuer)

    12/16/25 4:30:25 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    Director Lopez Esteban sold $18,721 worth of shares (166 units at $112.78), decreasing direct ownership by 4% to 3,850 units (SEC Form 4)

    4 - Addus HomeCare Corp (0001468328) (Issuer)

    12/8/25 4:30:33 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    $ADUS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Addus HomeCare Announces Fourth Quarter and Year End 2025 Financial Results

    Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025 Highlights: Net Service Revenues Increase 25.6% to $373.1 Million Net Income of $29.8 Million, or $1.61 per Diluted Share Adjusted Net Income per Diluted Share Increases 28.3% year-over-year to $1.77 Adjusted EBITDA Increases 33.3% year-over-year to $50.3 Million Cash Flow from Operations of $18.8 Million Overview Net service revenues were $373.1 million for the fourth quarter of 2025, a 25.6% increase compared with $297.1 million for the fourth quarter of 2024. Net income was $29.

    2/23/26 4:05:00 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    Addus HomeCare Announces Fourth Quarter and Year-End 2025 Earnings Release and Conference Call

    Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that it will release earnings for the fourth quarter and year-ended December 31, 2025, on Monday, February 23, 2026, after the market close. Addus HomeCare will host a conference call on Tuesday, February 24, 2026, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, Brian Poff, Executive Vice President and CFO, and Heather Dixon, President and COO. To access the live call, dial (833) 629-0620 (international dial-in number is (412) 317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available

    2/9/26 11:00:00 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    Addus HomeCare to Participate in Upcoming Investor Conferences in November

    Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its participation at the following investor conferences in November: 2025 UBS Global Healthcare Conference in Palm Beach Gardens, Florida. Dirk Allison, Chairman and Chief Executive Officer, Heather Dixon, President and Chief Operating Officer and Brian Poff, Executive Vice President and Chief Financial Officer, will present at 9:15 a.m. Central Time / 10:15 a.m. Eastern Time on Wednesday, November 12, 2025. 2025 Stephens Annual Investment Conference in Nashville, Tennessee. Dirk Allison, Chairman and Chief Executive Officer, Heather Dixon, President and Chief Operating Officer and Brian Poff, E

    11/5/25 11:00:00 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    $ADUS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Truist initiated coverage on Addus HomeCare with a new price target

    Truist initiated coverage of Addus HomeCare with a rating of Buy and set a new price target of $135.00

    1/7/26 9:08:42 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    BMO Capital Markets initiated coverage on Addus HomeCare with a new price target

    BMO Capital Markets initiated coverage of Addus HomeCare with a rating of Market Perform and set a new price target of $120.00

    11/13/25 9:11:54 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    UBS initiated coverage on Addus HomeCare with a new price target

    UBS initiated coverage of Addus HomeCare with a rating of Buy and set a new price target of $145.00

    9/2/25 8:34:27 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    $ADUS
    SEC Filings

    View All

    Addus HomeCare Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Addus HomeCare Corp (0001468328) (Filer)

    2/23/26 4:16:02 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Addus HomeCare Corporation

    SCHEDULE 13G/A - Addus HomeCare Corp (0001468328) (Subject)

    2/12/26 10:25:43 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Addus HomeCare Corporation

    SCHEDULE 13G/A - Addus HomeCare Corp (0001468328) (Subject)

    2/10/26 5:19:18 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    $ADUS
    Leadership Updates

    Live Leadership Updates

    View All

    Addus HomeCare Names Heather Dixon President and Chief Operating Officer

    Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced that Heather Dixon has been appointed President and Chief Operating Officer of Addus and is expected to join the Company in that role in mid-September. W. Bradley Bickham, the Company's current President and Chief Operating Officer, has been appointed advisor to the Chief Executive Officer upon Dixon joining and has agreed to serve in that role until his previously announced retirement in March 2026. Commenting on today's announcement, Dirk Allison, Chairman and Chief Executive Officer, stated, "We are excited to welcome Heather Dixon as our new President and Chief Operating Officer. Heather's exte

    8/7/25 8:00:00 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    Axonics® Announces Appointment of Dr. Esteban López to its Board of Directors

    Axonics, Inc. (NASDAQ:AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced the appointment of Esteban López, M.D., MBA, to its board of directors, effective immediately. "Axonics is fortunate to have someone of Dr. López's character and extensive experience join our board of directors," said Raymond W. Cohen, CEO of Axonics. "Given his thought leadership in healthcare, Dr. López will be a valuable adviser to Axonics as we continue to execute on our ambitious growth objectives." Dr. López is the Americas healthcare and life sciences Market Lead at Google Cloud with multinational

    7/15/21 6:00:00 AM ET
    $AXNX
    $ADUS
    Medical/Dental Instruments
    Health Care
    Medical/Nursing Services

    Addus HomeCare Announces Retirement of Laurie Manning

    Robby Stevenson Named Company's Chief Human Resource Officer Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that Laurie Manning retired from her position as Executive Vice President and Chief Human Resource Officer, effective June 11, 2021. Robby Stevenson, Senior Vice President of Human Resources, has been promoted to Executive Vice President and Chief Human Resource Officer and will assume leadership in that area. Commenting on the announcement, Dirk Allison, Chairman and Chief Executive Officer, said, "Laurie has played an important role in the growth and success of Addus since she joined the Company in 2017. Our employees are our most impor

    6/14/21 8:00:00 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    $ADUS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Addus HomeCare Corporation

    SC 13G - Addus HomeCare Corp (0001468328) (Subject)

    11/13/24 9:44:25 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by Addus HomeCare Corporation (Amendment)

    SC 13G/A - Addus HomeCare Corp (0001468328) (Subject)

    2/13/24 4:55:59 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by Addus HomeCare Corporation (Amendment)

    SC 13G/A - Addus HomeCare Corp (0001468328) (Subject)

    1/22/24 2:03:09 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    $ADUS
    Financials

    Live finance-specific insights

    View All

    Addus HomeCare Announces Fourth Quarter and Year End 2025 Financial Results

    Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025 Highlights: Net Service Revenues Increase 25.6% to $373.1 Million Net Income of $29.8 Million, or $1.61 per Diluted Share Adjusted Net Income per Diluted Share Increases 28.3% year-over-year to $1.77 Adjusted EBITDA Increases 33.3% year-over-year to $50.3 Million Cash Flow from Operations of $18.8 Million Overview Net service revenues were $373.1 million for the fourth quarter of 2025, a 25.6% increase compared with $297.1 million for the fourth quarter of 2024. Net income was $29.

    2/23/26 4:05:00 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    Addus HomeCare Announces Fourth Quarter and Year-End 2025 Earnings Release and Conference Call

    Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that it will release earnings for the fourth quarter and year-ended December 31, 2025, on Monday, February 23, 2026, after the market close. Addus HomeCare will host a conference call on Tuesday, February 24, 2026, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, Brian Poff, Executive Vice President and CFO, and Heather Dixon, President and COO. To access the live call, dial (833) 629-0620 (international dial-in number is (412) 317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available

    2/9/26 11:00:00 AM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    Addus HomeCare Announces Third Quarter 2025 Financial Results

    Expands in Texas with Acquisition of Personal Care Operations of Del Cielo Home Care Services Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the third quarter and nine months ended September 30, 2025. Third Quarter 2025 Highlights: Net Service Revenues Grow 25.0% to $362.3 Million Net Income of $22.8 Million, or $1.24 per Diluted Share Adjusted Net Income per Diluted Share Increases 20.0% year-over-year to $1.56 Adjusted EBITDA Increases 31.6% year-over-year to $45.1 Million Cash Flow from Operations of $51.3 Million Completed Del Cielo acquisition on October 1, 2025 Overview Net service revenu

    11/3/25 4:05:00 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care